Role of the A+ helix in heparin binding to protein C Inhibitor

Thrombosis and Haemostasis

Volumn 75, Issue 5, 1996, Pages 760-766

  Elisen, Marc G L M ^a   Maseland, Machiel H H ^a   Church, Frank C ^b   Bouma, Bonno N ^a   Meijers, Joost C M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; PLASMINOGEN ACTIVATOR INHIBITOR 3;

ALPHA HELIX; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL STRAIN BHK; CONTROLLED STUDY; DRUG BINDING; DRUG BINDING SITE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030013306     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1650363     Document Type: Article

References (31)

1. Suzuki K, Nishioka J, Hashimoto S. Protein C inhibitor. Purification from human plasma and characterization. J Biol Chem 1983; 258: 163-8.
2. Meijers JCM, Kanters DHAJ, Vlooswijk RAA, van Erp HE, Hessing M, Bouma BN. Inactivation of human plasma kallikrein and factor XIa by protein C inhibitor. Biochemistry 1988; 27: 4231-7.
3. Shirk RA, Phillips JC, Church FC. The molecular biology of protein C inhibitor. In: Molecular Basis of Thrombosis and Hemostasis. High KA, Roberts HR (eds). New York: Marcel Dekker 1995; pp 447-57.
4. Heeb MJ, España F, Geiger M, Collen D, Stump DC, Griffin JH. Immunological identity of heparin-dependent plasma and urinary protein C inhibitor and plasminogen activator inhibitor-3. J Biol Chem 1987; 263: 15813-6.
5. Geiger M. Protein C inhibitor/plasminogen activator inhibitor 3. Fibrinolysis 1988; 2: 183-8.
6. 1,-antitrypsin for structure and function of serpins. Biochemistry 1989; 28: 8951-66.
7. Travis J, Salvesen GS. Human plasma proteinase inhibitors. Annu Rev Biochem 1983; 52: 655-709.
8. Suzuki K, Nishioka J, Kusumoto H, Hashimoto S. Mechanism of inhibition of activated protein C by protein C inhibitor. J Biochem 1984; 95: 187-95.
9. Suzuki K, Deyashiki Y, Nishioka J, Toma K. Protein C inhibitor: structure and function, Thromb Haemost 1989; 61: 337-42.
10. Pratt CW, Church FC. Heparin binding to protein C inhibitor. J Biol Chem 1992; 267: 8789-94.
11. Griffith MJ. Heparin-catalyzed inhibitor protease reactions: kinetic evidence for a common mechanism of action of heparin. Proc Natl Acad Sci USA 1983; 80: 5460-5.
12. Kazama Y, Niwa M, Yamagishi R, Takahashi K, Sakuragawa N, Koide T. Specificity of sulfated polysaccharides to accelerate the inhibition of activated protein C by protein C inhibotor. Thromb Res 1987; 48: 179-85.
13. Cardin AD, Weintraub HJR. Molecular modeling of protein-glycosaminoglycan interactions. Arteriosclerosis 1989; 9: 21-32.
14. Margalit H, Fisher N, Ben-Sasson S. Comparative analysis of structurally defined heparin binding sequences reveals a distinct spatial distribution of basic residues. J Biol Chem 1993; 268: 19228-31.
15. Kuhn LA, Griffin JH, Fisher CL, Greengard JS, Bouma BN, Espana F, Tainer JA. Elucidating the structural chemistry of glycosaminoglycan recognition by protein C inhibitor. Proc Natl Acad Sci USA 1990; 87: 8506-10.
16. Pratt CW, Whinna HC, Church FC. A comparison of three heparin binding serine protease inhibitors. J Biol Chem 1992; 267: 8795-801.
17. Shirk RA, Elisen MGLM, Meijers JCM, Church FC. Role of the H helix in heparin binding to protein C inhibitor. J Biol Chem 1994; 269: 28690-5.
18. Meijers JCM, Chung DW. Evidence for a glycine residue at position 316 in human protein C inhibitor. Thromb Res 1990; 59: 389-93.
19. Vandeyar MA, Weiner MP, Hutton CJ, Batt CA. A simple and rapid method for the selection of oligodeoxynucleotide-directed mutants. Gene 1988; 65: 129-33.
20. Meijers JCM, Davie EW, Chung DW. Expression of human blood coagulation factor XI: characterization of the defect in factor XI type III deficiency. Blood 1992; 79: 1435-40.
21. Laurell M, Carlson T, Stenflo J. Monoclonal antibodies against the heparin dependent protein C inhibitor suitable for purification and assay of inhibitor complexes. Thromb Haemost 1988; 60: 334-9.
22. Chase T, Shaw E. Titration of trypsin, plasmin and thrombin with p-nitrophenyl p'-guanidinobenzoate HCI. Meth Enzymol 1970; 19: 20-7.
23. Hackeng TM, Hessing M, van't Veer C, Meijer-Huizinga F, Meijers JCM, de Groot PG, van Mourik JA, Bouma BN. Protein S binding to human endothelial cells is required for expression of cofactor activity for activated protein C. J Biol Chem 1983; 268: 3993-4000.
24. 1,-proteinase inhibitor. Biochemistry 1993; 32: 9230-5.
25. Hermans JM, Stone SR. Interaction of activated protein C with serpins. Biochem J 1993; 295: 239-45.
26. Morrison JF. The slow-binding and slow tight-binding inhibition of enzyme catalysed reactions. TIBS 1982; 7: 102-5.
27. Cha S. Tight binding inhibitors - I. Kinetic behaviour. Biochemical Pharmacology 1975; 25: 2695-702.
28. Morrison JF, Walsh CT. The behaviour and significance of slow binding enzyme inhibitors. Adv Enzymol 1988; 61: 201-301.
29. Suzuki K, Deyashiki J, Nishioka K, Kurachi M, Akiras S, Yamamoto S, Hashimoto S. Characterization of a cDNA for human protein C inhibitor. A new member of the plasma serine protease superfamily. J Biol Chem 1987; 262: 611-6.
30. Laurell M, Stenflo J. Protein C inhibitor from human plasma: characterisation of native and cleaved inhibitor and demonstration of inhibitor complexes with plasma kallikrein. Thromb Haemost 1989; 62: 885-91.
31. 1-antitrypsin with computer graphics. Protein Engineering 1987; 1: 471-5.